This document discusses gall bladder cancer. It notes that gall bladder cancer is rare and traditionally incurable, with late presentation and disseminated disease at diagnosis leading to a dismal prognosis. Complete surgical resection is the main treatment option, with a 5-year survival rate of only 5%. Risk factors include chronic cholelithiasis and inflammation. Staging and surgical management depend on the extent of disease, with more advanced stages requiring liver resection or extended surgery.
GB cancer is the 5th most common GIT malignancy(worldwide).200 years later it is still considered to be a highly malignant disease with a poor survival rate
.Here is a brief description regarding
This Presentation gives summarized overview of Gall Bladder Carcinoma especially the management as per latest National Comprehensive Cancer Network(NCCN) Guidelines version 2.2013
Gall bladder carcinoma seen in Indian popluation most common in women and presents at a very late stage .Survival is in months hence palliative treatment is being preferred .
GB cancer is the 5th most common GIT malignancy(worldwide).200 years later it is still considered to be a highly malignant disease with a poor survival rate
.Here is a brief description regarding
This Presentation gives summarized overview of Gall Bladder Carcinoma especially the management as per latest National Comprehensive Cancer Network(NCCN) Guidelines version 2.2013
Gall bladder carcinoma seen in Indian popluation most common in women and presents at a very late stage .Survival is in months hence palliative treatment is being preferred .
Sites of the highest risk are the duodenum, for adenocarcinomas, and the ileum, for carcinoids and lymphomas.
In industrialized countries, small bowel cancers are predominantly adenocarcinomas;
In developing countries, lymphomas are much more common.
The incidence of small bowel cancer rises with age and has generally been higher among males than among females.
The risk factors for small bowel cancer include
Dietary factor
Cigarette smoking,
Alcohol intake,
Medical conditions -Crohn's disease, familial adenomatous polyposis, cholecystectomy, peptic ulcer disease, and cystic fibrosis.
The protective factors may include rapid cell turnover, a general absence of bacteria, an alkaline environment, and low levels of activating enzymes of precarcinogens.
Cancer that forms in tissues of the bladder (the organ that stores urine). Most bladder cancers are transitional cell carcinomas (cancer that begins in cells that normally make up the inner lining of the bladder). Other types include squamous cell carcinoma (cancer that begins in thin, flat cells) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). The cells that form squamous cell carcinoma and adenocarcinoma develop in the inner lining of the bladder as a result of chronic irritation and inflammation.
Sites of the highest risk are the duodenum, for adenocarcinomas, and the ileum, for carcinoids and lymphomas.
In industrialized countries, small bowel cancers are predominantly adenocarcinomas;
In developing countries, lymphomas are much more common.
The incidence of small bowel cancer rises with age and has generally been higher among males than among females.
The risk factors for small bowel cancer include
Dietary factor
Cigarette smoking,
Alcohol intake,
Medical conditions -Crohn's disease, familial adenomatous polyposis, cholecystectomy, peptic ulcer disease, and cystic fibrosis.
The protective factors may include rapid cell turnover, a general absence of bacteria, an alkaline environment, and low levels of activating enzymes of precarcinogens.
Cancer that forms in tissues of the bladder (the organ that stores urine). Most bladder cancers are transitional cell carcinomas (cancer that begins in cells that normally make up the inner lining of the bladder). Other types include squamous cell carcinoma (cancer that begins in thin, flat cells) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). The cells that form squamous cell carcinoma and adenocarcinoma develop in the inner lining of the bladder as a result of chronic irritation and inflammation.
Bladder Cancer Diagnostic-Initial Team ProjectSagar Desai
A mini-project to find biomarkers for bladder cancer diagnosis. We narrowed down our list of viable candidates down to three that could be used in combination to provide sensitivity and specificity values greater than 94%. Furthermore, we calculated long-term monitoring and payor costs as well as potential profit.
This is a powerpoint on Bladder Cancer. Sources are on the last slide of the powepoint! No copy right intended! Enjoy! I hope you learn a lot and I hope you live your life Bladder Cancer free! Also the red words are what I would say during the presentation, basically extra details! So keep that in mind!
-Shelby
Indian Dental Academy: will be one of the most relevant and exciting training center with best faculty and flexible training programs for dental professionals who wish to advance in their dental practice,Offers certified courses in Dental implants,Orthodontics,Endodontics,Cosmetic Dentistry, Prosthetic Dentistry, Periodontics and General Dentistry.
Target audience : Oncology fellows and Oncologists.
Four challenging cases of Bladder cancer and managing decisions including latest management principles are discussed here.
The stomach J-shaped. It has two surfaces (the anterior & posterior), two curvatures (the greater & lesser), two orifices (the cardia & pylorus). It has fundus, body and pyloric antrum.
Blood supply
The left gastric artery
Right gastric artery
Right gastro-epiploic artery
Left gastro-epiploic artery
Short gastric arteries
Stomach cancer begins when cancer cells form in the inner lining of your stomach. These cells can grow into a tumor. Also called gastric cancer, the disease usually grows slowly over many years.
It could be:
malignant or benign
primary or secondary
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
2. OVERVIEW
GB cancer is rare – traditionally incurable
Late presentation
Disseminated disease
Dismal prognosis and lack of effective therapy
Blalock – “ In malignancy of GB, when a diagnosis
can be made without exploration, no operation should
be performed, inasmuch as it only shortens the
patient’s life”
3. TENDENCY TO SPREAD
Lymphatics
Hematogenous
Peritoneal
Along biopsy tracts and wounds
Overall 5 year survival : 5%
Median survival : < 6 months
Treatment : Complete surgical resection
4. EPIDEMIOLOGY
Highest incidence:
- Females in India : (21.5 per 100,000)
- Females in Pakistan : (13.8 per 100,000)
In USA : Females ( 2 per 100,000)
Female : male – 3:1
Increase in age : increase in incidence
Obesity : BMI 30 – 34.9 vs 18.5 – 24.9 ---RR of
death from CA GB 2.13
5. ETIOLOGY
Most consistent risk factor : Cholelithiasis with
chronic inflammation (75-90%)
RR of CA GB with stone >3cm – 10.1
Possibility of stone formation and CA sharing
same risk factors
Stones may prompt a radiological workup /
cholecystectomy resulting in detection
11. ANATOMY OF GALL BLADDER
GB partially intraperitoneal structure – attached
to liver on segment IV b and V
Side of GB attached to liver bed – no peritoneal
covering
“Cystic plate” – fibrous lining
In simple cholecystectomy – Plane between
muscularis of GB and cystic plate dissected
---INADEQUATE FOR CA GB
12.
13. ANATOMY
Body and fundus : Lies at a distance from major
inflow structures
Limited segmental resection (Segment IV b and
V) adequate
Infundibulum : Encroaches onto the porta
hepatis
Tumors of this area – involves porta
Prepare to perform bile duct resection/ major
hepatic resection
19. CLINICAL PRESENTATION
SCENARIOS:
1. Final pathology after routine cholecystectomy
identifies CA GB
2. GB cancer discovered intraoperatively
3. GB cancer suspected before surgery
20. HISTORY
Constant RUQ pain – rather than episodic
crampy pain of biliary colic
Elderly patients
Weight loss
Anorexia
Jaundice
22. LAB EXAMINATION (HELPFUL IN
ADVANCED DISEASE)
Anemia
Hypoalbuminemia
Leukocytosis
Elevated bilirubin
Elevated Alkaline Phosphatase
Tumor markers:
- CEA : 90% specific but lacks sensitivity (50%)
- CA19-9 : More consistent marker
Sensitivity : 75%
Specificity : 75%
23. RADIOLOGY
USG : Excellent modality for GB
Findings :
- Discontinuous mucosa
- Echogenic mucosa
- Submucosal echogenicity
Doppler assessment of blood flow: Differentiates
malignant from benign
Limitation : Unable to stage (Nodes cannot be
visualised)
24. CT/MRI
Can assess extent of disease
Detects presence of distant metastases
MC finding : Mass in GB
Assessment of LN:
- Size > 1cm
- Ring like heterogenous enhancement
25.
26. CT/MRI
CT : 71 – 84 % accurate
• 79% can differentiate between T1 and T2
• 93% between T2 and T3
• 100% between T3 and T4
MRI:
- 70 – 100% sensitive for hepatic invasion
- 60 – 75% sensitive for LN spread
27. FDG PET scan :
- More accurate than CT in diagnosing metastatic
disease
- Poor in differentiating benign inflammatory state
vs malignancy
28.
29. PRE-OPERATIVE PATHOLOGICAL
DIAGNOSIS
If CA-GB suspected on clinical and radiological
grounds – Histological diagnosis NOT necessary
Biopsy increases risk of seeding
If concern for GB malignancy significant –
Unwise to perform simple cholecystectomy
For unresectable disease – Percutaneous needle
biopsy – 90% accurate
30. BILE CYTOLOGY
Less risky way of making diagnosis without risk
of peritoneal seeding.
Justifiable in patients undergoing ERCP/PTC
If NOT - unwarranted
34. SURGICAL MANAGEMENT
Benign polyp :
- Adenomatous polyp – ONLY polypoidal lesion
with malignant potential
- Cholesterol polyp – MC polyp
Indicators for cholecystectomy:
- Single polyp
- Size > 1 cm
- Age > 50 years
35. Old concept – Offer OPEN cholecystectomy
Current concept – Offer Laparoscopic
cholecystectomy + Frozen
Diagnosis – USG required
If polyp presents with abdominal pain – rule out
other causes
36. INCIDENTALLY DETECTED GB CA
Incidence : 0.27 – 2.1%
If diagnosis made by frozen – Prepare for
curative resection
IF NOT COMFORTABLE – REFER
NO EFFECT ON OUTCOME
37. T1a with margins negative : Standard
cholecystectom cures 85 – 100%
T1b – controversial
T2 onwards – plan liver resection
38. NON CURATIVE
CHOLECYSTECTOMY
Careful work up required which includes :
- Reviewing pre-cholecystectomy USG to localise
extent
- Discuss case with operating surgeon
- Re-review T stage and margins pathologically
39. T1B LESIONS
If cystic duct stump / margins +ve –
Bile duct resection and reconstruction
OR
Re-resection of cystic duct stump and frozen
proceed
40. EXTENT OF RESECTION BY STAGE
Rational approach to CA GB depends on :
- Stage of disease
- Location of tumour
- Margins status – if cholecystectomy has already
been performed.
- Whether a prior noncurative cholecystectomy has
been performed
41. T1a – Simple cholecystectomy
T1b – Higher locoregional recurrence rates after
simple cholecystectomy
T2,T3 – Complete enbloc resection with segment
Ivb and V of liver
42. If invasion of hepatic inflow vascular structures
is documented :
- Extended right hepatectomy + LN clearance of
hepatoduodenal ligament + negative cystic
duct/bile duct margins
- Abandon major resection IF:
1. Nodal spread
2. Metastases
43. LIVER RESECTION
Goal : To ensure a margin of 1-2 cm
Anatomic resection – better than wedge resection
If excision of segment IV b and V inadequate –
DO extended right hepatectomy:
ESP in cases of large tumors invading portal
pedicle
Tumors of lower end of GB encroaching onto
porta
44. If isolated invasion of organ system present
EG: Stomach , duodenum, colon
In absence of distant metastases – DO local
resection
45. LYMPH NODAL DISSECTION
Weigh risks vs benefits
Range of operations include : Excision of cystic
duct node– Portal clearance–
pancreaticoduodencetomy
1st
manouvre : Mobilisation of duodenum – To
assess aortocaval and retropancreatic nodes
Assess celiac node LN – If suspicious DO frozen
and terminate procedure IF MALIGNANT
46. WHETHER ROUTINE BILE DUCT
RESECTION IS NECESSARY FOR
ADEQUATE LN CLEARANCE??
Excising extrahepatic bile duct – makes LN
dissection easy
Increases morbidity of operation
No difference noted in the number of LN
harvested with OR without bile duct resection
In general – bile duct resection NOT needed----
Unless suspicion of PORTA infiltration
47. Stage of disease and NOT extent of resection
determines survival of patients
48.
49. DID YOU KNOW?
“Honeymoon and alcohol”
Roots trace back to Babylon
Tradition for the soon to be father- in-law to
supply his daughter’s fiance with a month of
mead
Time period referred to as the HONEYMONTH
50.
51. DID YOU KNOW?
Adolf Hitler was one of the world’s best known abstainers from
alcohol.